Canopy Growth Corporation (CGC) vs Opus Genetics, Inc. (IRD)

A side-by-side comparison of Canopy Growth Corporation and Opus Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CGC vs IRD

growth of $100 · dividends reinvested · last 2y
CGC -79.9% (-55.2%/yr)IRD +239.5% (+84.3%/yr)IRD compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020252026$20$340
CGC IRD

CGC vs IRD: by the numbers

  • •CGC is the larger company ($375M vs $363M market cap).
  • •Both run net losses; CGC's is the smaller (-81.04% vs -1091.82% net margin).
  • •IRD grew revenue faster over the past five years (150.49% vs -12.47% CAGR).

Metrics side by side

Valuation

MetricCGCIRD
P/S ratio1.6236.82
P/B ratio0.77N/A

Profitability

MetricCGCIRD
Gross margin25.47%99.87%
Operating margin-31.98%-271.90%
Net margin-81.04%-1091.82%
ROE-38.57%N/A
ROIC-10.85%-59.29%

Growth (annualized)

MetricCGCIRD
Revenue CAGR (5Y)-12.47%150.49%
Total return CAGR (5Y)-63.36%N/A

Frequently asked

Which has grown faster, CGC or IRD?
Over the past five years, IRD grew revenue faster — CGC at a -12.47% CAGR versus IRD at 150.49%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.